Injection of triamcinolone acetonide into the posterior sub-tenon capsule for treatment of diabetic macular edema.

Purpose:To compare eyes that received treatment with untreated fellow eyes to assess the effectiveness of injection of 20 mg of triamcinolone acetonide (TA) into the posterior sub-Tenon capsule for treatment of diabetic macular edema (DME).Methods:Nine adult patients (mean age, 60.4 years) with DME